Tiagabine, Blood - NMS Labs

Method(s)

High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS)

Suggested CPT Code(s)

80199

New York State Approval Status

Approved

Turnaround Time

7 days

Test Includes


1	Tiagabine	Gabitril®	High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS)	ng/mL	4	Anticonvulsant, Antiepileptic

Compliance Statement

This test was developed and its performance characteristics determined by NMS Labs. It has not been cleared or approved by the US Food and Drug Administration.

Sample Type

Blood

Requested Volume

1 mL

Minimum Volume

0.4 mL

Special Handling

None

Sample Container

Lavender top tube (EDTA)

Additional Collection Instructions

Transport Temperature

Refrigerated

Light Protection

Not Required

Rejection Criteria

None

Rejection criteria pertain to clinical sample submissions only.

Stability

Room Temperature: 30 day(s)
Refrigerated: 30 day(s)
Frozen (-20 °C): 7 month(s)


1	Tiagabine	Gabitril®	High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS)	ng/mL	4	Anticonvulsant, Antiepileptic

Example Report (Negative)

Example Report (Positive)

Interface Map

4479B Tiagabine, Blood - Current Version
Analyte	Units	Analyte Mapping Code	LOINC®
Tiagabine	ng/mL	TIAGABINE

LOINC^® Information

4479B Tiagabine, Blood - Current Version
Analyte	Units	Analyte Mapping Code	LOINC®
Tiagabine	ng/mL	TIAGABINE

Some LOINC^® codes may not have been assigned or are not available.

This material contains content from LOINC (http://loinc.org). LOINC is copyright ^® 1995-2023, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee and is available at no cost under the license at http://loinc.org/license. LOINC^® is a registered United States trademark of Regenstrief Institute, Inc.

The CPT Codes provided in this document are based on AMA Guidelines and are for informational purposes only. NMS Labs Does not assume responsibility for billing errors due to Reliance on the CPT Codes listed in this document.

*The information contained in this document represents database configurations, as they will appear on the effective date listed above.